Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection Open Access

Abstract

We describe a case of acute cytomegalovirus (CMV) infection complicated by acquired antiphospholipid antibodies and splenic thrombi. We discuss the associations between CMV infection and thrombosis risk and correlation with antiphospolipid antibodies.

A previously healthy 32-year-old woman is hospitalized for acute abdominal pain and fever and found to have multiple splenic infarcts on an abdominal computed tomography (CT) scan. An infectious work-up is negative except for acute CMV, and a hypercoagulable work-up is only positive for antiphospholipid antibodies. The patient is discharged and placed on anti-coagulation therapy for 6 months.

Co-incident thrombosis and antiphospholipid antibody syndrome can occur with acute viral infections, including CMV. We discuss the viral infection-associated increased risk of developing blood clots and antiphospholipid antibodies as being either correlative with or causative of viral-induced thrombosis.

Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000032
2019-09-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/acmi/1/7/acmi000032.html?itemId=/content/journal/acmi/10.1099/acmi.0.000032&mimeType=html&fmt=ahah

References

  1. Gardiner C, Hills J, Machin SJ, Cohen H. Diagnosis of antiphospholipid syndrome in routine clinical practice. Lupus 2013; 22:18–25 [View Article]
    [Google Scholar]
  2. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010; 20:202–213 [View Article]
    [Google Scholar]
  3. Swanson EC, Schleiss MR. Congenital cytomegalovirus infection: new prospects for Prevention and therapy: for pediatric clinics of North America: advances in evaluation, diagnosis and treatment of pediatric infectious disease. Pediatric clinics of North America 2013; 60:10
    [Google Scholar]
  4. Luscalov S, Loga L, Dican L, Junie LM. Cytomegalovirus infection in immunosuppressed patients after kidney transplantation. Clujul Medical 2016; 89:343–346
    [Google Scholar]
  5. Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. J Intern Med 2006; 259:219–246 [View Article]
    [Google Scholar]
  6. Abgueguen P, Delbos V, Chennebault JM, Payan C, Pichard E. Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis 2003; 36:e134–e139 [View Article]
    [Google Scholar]
  7. Justo D, Finn T, Atzmony L, Guy N, Steinvil A. Thrombosis associated with acute cytomegalovirus infection: a meta-analysis. Eur J Intern Med 2011; 22:195–199 [View Article]
    [Google Scholar]
  8. Arav-Boger R, Reif S, Bujanover Y. Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 1995; 126:586–588 [View Article]
    [Google Scholar]
  9. Schambeck CM, Hinney K, Gleixner J, Keller F. Venous thromboembolism and associated high plasma factor VIII levels: linked to cytomegalovirus infection?. Thromb Haemost 2000; 83:510–511
    [Google Scholar]
  10. Rovery C, Granel B, Parola P, Foucault C, Brouqui P. Acute cytomegalovirus infection complicated by venous thrombosis: a case report. Ann Clin Microbiol Antimicrob 2005; 4:11 [View Article]
    [Google Scholar]
  11. Sutherland MR, Raynor CM, Leenknegt H, Wright JF, Pryzdial EL. Coagulation initiated on herpesviruses. Proc Natl Acad Sci USA 1997; 94:13510–13514 [View Article]
    [Google Scholar]
  12. Squizzato A, Gerdes VEA, Büller HR. Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost 2005; 93:403–410 [View Article]
    [Google Scholar]
  13. van de Berg PJ, Yong SL, Remmerswaal EB, van Lier RA, ten Berge IJ. Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin Vaccine Immunol 2012; 19:772–779 [View Article]
    [Google Scholar]
  14. Rahbar A, Söderberg-Nauclér C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 2005; 79:2211–2220 [View Article]
    [Google Scholar]
  15. Delbos V, Abgueguen P, Chennebault JM, Fanello S, Pichard E. Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect 2007; 54:e47–e50 [View Article]
    [Google Scholar]
  16. Labarca JA, Rabaggliati RM, Radrigan FJ, Rojas PP, Perez CM et al. Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 1997; 24:197–200 [View Article]
    [Google Scholar]
  17. Uthman I, Tabbarah Z, Gharavi AE. Hughes syndrome associated with cytomegalovirus infection. Lupus 1999; 8:775–777 [View Article]
    [Google Scholar]
  18. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in Non-SLE disorders. Ann Intern Med 1990; 112:682–698 [View Article]
    [Google Scholar]
  19. Mannoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J et al. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunology 1987; 69:557–565
    [Google Scholar]
  20. Asherson RA, Cervera R. Antiphospholipid Antibodies and infections. Ann Rheum Dis 2003; 62:388–393 [View Article]
    [Google Scholar]
  21. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41:8–15 [View Article]
    [Google Scholar]
  22. Blank M, Krause I, Fridkin M, Keller N, Kopolovic J et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109:797–804 [View Article]
    [Google Scholar]
  23. Mackworth-Young CG, Harris EN, Steere AC, Rizvi F, Malawista SE et al. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 1988; 31:1052–1056 [View Article]
    [Google Scholar]
  24. Adebajo AO, Charles P, Maini RN, Hazleman BL. Autoantibodies in malaria, tuberculosis and hepatitis B in a West African population. Clin Exp Immunol 1993; 92:73–76 [View Article]
    [Google Scholar]
  25. Hasegawa I, Suzuki T, Ishii S, Takakuwa K, Tanaka K. Establishment of two distinct anti-cardiolipin antibody-producing cell lines from the same individual by Epstein-Barr virus transformation. Thromb Res 1994; 74:77–84 [View Article]
    [Google Scholar]
  26. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019–1027 [View Article]
    [Google Scholar]
  27. Zhu L, Li C, Liu N, Yang X, Jia RL et al. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol 2017; 36:401–406 PubMed PMID: 28050648 [View Article]
    [Google Scholar]
  28. Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y et al. First-line, Non-criterial antiphospholipid antibody testing for the diagnosis of antiphospholipid syndrome in clinical practice: a combination of anti-beta2-glycoprotein I domain I and phosphatidylserine-dependent Antiprothrombin antibodies. Arthritis Care Res 2017 PubMed PMID: 28686816
    [Google Scholar]
  29. Lee JS, Gu J, Park HS, Yoo HJ, Kim HK. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk. Clin Chem Lab Med 2017; 55:882–889 PubMed PMID: 28002027 [View Article]
    [Google Scholar]
  30. Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K et al. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study. Lupus 2017; 26:266–276 PubMed PMID: 27510605 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000032
Loading
/content/journal/acmi/10.1099/acmi.0.000032
Loading

Data & Media loading...

Most cited Most Cited RSS feed